| Ident. | Authors (with country if any) | Title |
|---|
| 000373 (2017) |
Laurence Persegol [France] ; Maryam Darabi [France] ; Carolane Dauteuille [France] ; Marie Lhomme [France] ; Sandrine Chantepie [France] ; Kerry-Anne Rye [Australie] ; Patrice Therond [France] ; M John Chapman [France] ; Robert Salvayre [France] ; Anne Negre-Salvayre [France] ; Philippe Lesnik [France] ; Serge Monier [France] ; Anatol Kontush [France] | Small, dense high-density lipoproteins display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate. |
| 000A84 (2017) |
Emiel P C. Van Der Vorst [Allemagne] ; Kosta Theodorou [Pays-Bas] ; Yongzheng Wu [France] ; Marten A. Hoeksema [Pays-Bas] ; Pieter Goossens [France] ; Christina A. Bursill [Australie] ; Taghi Aliyev [Pays-Bas] ; Leonie F A. Huitema [Pays-Bas] ; Sander W. Tas [Pays-Bas] ; Ine M J. Wolfs [Pays-Bas] ; Marijke J E. Kuijpers [Pays-Bas] ; Marion J. Gijbels [Pays-Bas] ; Casper G. Schalkwijk [Pays-Bas] ; Debby P Y. Koonen [Pays-Bas] ; Shahla Abdollahi-Roodsaz [Pays-Bas] ; Kimberly Mcdaniels [États-Unis] ; Chih-Chieh Wang [États-Unis] ; Michael Leitges [Norvège] ; Toby Lawrence [France] ; Jogchum Plat [Pays-Bas] ; Miranda Van Eck [Pays-Bas] ; Kerry-Anne Rye [Australie] ; Lhousseine Touqui [France] ; Menno P J. De Winther [Pays-Bas] ; Erik A L. Biessen [Allemagne] ; Marjo M P C. Donners [Pays-Bas] | High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling. |
| 000B16 (2017) |
Robert S. Rosenson [États-Unis] ; H Bryan Brewer [États-Unis] ; Philip J. Barter [Australie] ; Johan L M. Björkegren [États-Unis] ; M John Chapman [France] ; Daniel Gaudet [Canada] ; Daniel Seung Kim [États-Unis] ; Eric Niesor [Suisse] ; Kerry-Anne Rye [Australie] ; Frank M. Sacks [États-Unis] ; Jean-Claude Tardif [Canada] ; Robert A. Hegele [Canada] | HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. |
| 000D60 (2017) |
Benoit J. Arsenault [Canada] ; Francine Petrides [Australie] ; Fatiha Tabet [Australie] ; Weihang Bao [États-Unis] ; G Kees Hovingh [Pays-Bas] ; S Matthijs Boekholdt [Pays-Bas] ; Stéphane Ramin-Mangata [France] ; Olivier Meilhac [France] ; David Demicco [États-Unis] ; Kerry-Anne Rye [Australie] ; David D. Waters [États-Unis] ; John J P. Kastelein [Pays-Bas] ; Philip Barter [Australie] ; Gilles Lambert [France] | Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk. |
| 001D12 (2016) |
Blake J. Cochran [Australie] ; Liming Hou [Australie] ; Anil Paul Chirackal Manavalan [Australie] ; Benjamin M. Moore [Australie] ; Fatiha Tabet [Australie] ; Afroza Sultana [Australie] ; Luisa Cuesta Torres [Australie] ; Shudi Tang [Australie] ; Sudichhya Shrestha [Australie] ; Praween Senanayake [Australie] ; Mili Patel [Australie] ; William J. Ryder [Australie] ; Andre Bongers [Australie] ; Marie Maraninchi [France] ; Valerie C. Wasinger [Australie] ; Marit Westerterp [États-Unis] ; Alan R. Tall [États-Unis] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] | Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. |
| 002728 (2015) |
Joost Besseling [Pays-Bas] ; Kwok Leung Ong [Australie] ; Roeland Huijgen [Pays-Bas] ; Kerry-Anne Rye [Australie] ; G Kees Hovingh [Pays-Bas] ; Barbara A. Hutten [Pays-Bas] ; Gilles Lambert [France] | The impact of LDLR function on fibroblast growth factor 21 levels. |
| 002D21 (2015) |
Xian-Ming Du ; Mi-Jurng Kim ; Liming Hou ; Wilfried Le Goff ; M John Chapman ; Miranda Van Eck ; Linda K. Curtiss ; John R. Burnett ; Sian P. Cartland ; Carmel M. Quinn ; Maaike Kockx ; Anatol Kontush ; Kerry-Anne Rye ; Leonard Kritharides ; Wendy Jessup [Australie] | HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. |
| 003866 (2014) |
Fatiha Tabet [Australie] ; Kasey C. Vickers [États-Unis] ; Luisa F. Cuesta Torres [Australie] ; Carrie B. Wiese [États-Unis] ; Bassem M. Shoucri [États-Unis] ; Gilles Lambert [France] ; Claire Catherinet [Australie] ; Leonel Prado-Lourenco [Australie] ; Michael G. Levin [États-Unis] ; Seth Thacker [États-Unis] ; Praveen Sethupathy [États-Unis] ; Philip J. Barter [Australie] ; Alan T. Remaley [États-Unis] ; Kerry-Anne Rye [Australie] | HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells |
| 003993 (2014) |
Gilles Lambert [Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A David Marais [Afrique du Sud] | Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects. |
| 004187 (2014) |
Gilles Lambert [France, Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A. David Marais [Afrique du Sud] | Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects |
| 005997 (2012) |
Roeland Huijgen [Pays-Bas] ; S. Matthijs Boekholdt [Pays-Bas] ; Benoit J. Arsenault [Pays-Bas] ; WEIHANG BAO [États-Unis] ; Jean-Michel Davaine [France] ; Fatiha Tabet [Australie] ; Francine Petrides [Australie] ; Kerry-Anne Rye [Australie] ; David A. Demicco [États-Unis] ; Philip J. Barter [Australie] ; John J. P. Kastelein [Pays-Bas] ; Gilles Lambert [France, Australie] | Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control Study |
| 006950 (2011) |
Fatiha Tabet [Australie] ; Gilles Lambert [Australie, France] ; Luisa F. Cuesta Torres [Australie] ; LIMING HOU [Australie] ; Irene Sotirchos [Australie] ; Rhian M. Touyz [Canada] ; Alicia J. Jenkins [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] | Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages |
| 006F13 (2010) |
Estelle Nobécourt ; Fatiha Tabet ; Gilles Lambert [France] ; Rajesh Puranik [Australie] ; Shisan Bao [Australie] ; Ling Yan ; Michael J. Davies [Australie] ; Bronwyn E. Brown ; Alicia J. Jenkins [Australie] ; Gregory J. Dusting [Australie] ; David J. Bonnet ; Linda K. Curtiss ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] | Non-Enzymatic Glycation Impairs the Anti-Inflammatory Properties of Apolipoprotein A-I |
| 007484 (2010) |
Fatiha Tabet [Australie] ; Alan T. Remaley [États-Unis] ; Aude I. Segaliny [Australie] ; Jonathan Millet [Australie] ; LING YAN [Australie] ; Shirley Nakhla [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Gilles Lambert [France] | The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro |
| 007684 (2010) |
Estelle Nobecourt [Australie] ; Fatiha Tabet [Australie] ; Gilles Lambert [Australie] ; Rajesh Puranik [Australie] ; SHISAN BAO [Australie] ; LING YAN [Australie] ; Michael J. Davies [Australie] ; Bronwyn E. Brown [Australie] ; Alicia J. Jenkins [France] ; Gregory J. Dusting [Australie] ; David J. Bonnet [Australie] ; Linda K. Curtiss [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [États-Unis] | Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I |
| 007B44 (2009) |
Kerry-Anne Rye [Australie] ; Christina A. Bursill [Australie] ; Gilles Lambert [Australie, France] ; Fatiha Tabet [Australie] ; Philip J. Barter [Australie] | The metabolism and anti-atherogenic properties of HDL |
| 007B54 (2009) |
Fatiha Tabet [Australie] ; Alan T. Remaley [États-Unis] ; Aude I. Segaliny [Australie] ; Jonathan Millet [Australie] ; Ling Yan [Australie] ; Shirley Nakhla [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Gilles Lambert [Australie, France] | The 5A apolipoprotein A-I mimetic peptide displays anti-inflammatory and antioxidant properties in vivo and in vitro |
| 007B59 (2009) |
Juliana A. De Souza [France] ; Cecile Vindis [France] ; Anne Nègre-Salvayre [France] ; Kerry-Anne Rye [Australie] ; Martine Couturier [France] ; Patrice Therond [France] ; Sandrine Chantepie [France] ; Robert Salvayre [France] ; M John Chapman [France] ; Anatol Kontush [France] | Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I |
| 008160 (2009) |
Dick C. Chan [Australie] ; Gilles Lambert [Australie, France] ; P. Hugh R. Barrett [Australie] ; Kerry-Anne Rye [Australie] ; Esther M. M. Ooi [Australie] ; Gerald F. Watts [Australie] | Plasma Proprotein Convertase Subtilisin/ Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism? |
| 008206 (2009) |
Gilles Lambert [Australie, France] ; Francesca Charlton [Australie] ; Kerry-Anne Rye [Australie] ; Derek E. Piper [États-Unis] | Molecular basis of PCSK9 function |
| 008302 (2009) |
Amal Zerrad-Saadi [France] ; Patrice Therond [France] ; Sandrine Chantepie [France] ; Martine Couturier [France] ; Kerry-Anne Rye [Australie] ; M. John Chapman [France] ; Anatol Kontush [France] | HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis |
